Literature DB >> 20664469

The North American Neuroendocrine Tumor Society (NANETS) guidelines: mission, goals, and process.

Larry K Kvols1, Kari L Brendtro.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20664469     DOI： 10.1097/MPA.0b013e3181eb7451

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  12 in total

1.  Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Authors:  Stephan Petersenn; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

2.  Multidisciplinary reference centers: the care of neuroendocrine tumors.

Authors:  Simron Singh; Calvin Law
Journal:  J Oncol Pract       Date:  2010-11       Impact factor: 3.840

3.  A study of pipeline drugs in neuroendocrine tumors.

Authors:  Catherine T Anthony; Juan G Bastidas; Jessica L Thomson; John Lyons; James M Lewis; Joshua E Schwimer; Peter Casey; Jennifer Abadie; Daniel J Frey; Yi-Zarn Wang; J Philip Boudreaux; Eugene A Woltering
Journal:  J Gastrointest Cancer       Date:  2012-06

4.  Neuroendocrine liver metastases: contributions of endoscopy and surgery to primary tumor search.

Authors:  Herwig Cerwenka
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

Review 5.  Neuroendocrine tumours: the role of imaging for diagnosis and therapy.

Authors:  Martijn van Essen; Anders Sundin; Eric P Krenning; Dik J Kwekkeboom
Journal:  Nat Rev Endocrinol       Date:  2013-12-10       Impact factor: 43.330

6.  Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany.

Authors:  Hans Scherübl; Brigitte Streller; Roland Stabenow; Hermann Herbst; Michael Höpfner; Christoph Schwertner; Joachim Steinberg; Jan Eick; Wanda Ring; Krishna Tiwari; Sören M Zappe
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

7.  Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment.

Authors:  Angela Lamarca; Mauro Cives; Louis de Mestier; Joakim Crona; Francesca Spada; Kjell Öberg; Marianne Pavel; Teresa Alonso-Gordoa
Journal:  World J Gastroenterol       Date:  2021-03-14       Impact factor: 5.742

8.  Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program.

Authors:  Isabel Sevilla; Ángel Segura; Jaume Capdevila; Carlos López; Rocío García-Carbonero; Enrique Grande
Journal:  BMC Cancer       Date:  2016-11-07       Impact factor: 4.430

Review 9.  Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.

Authors:  Vladimir Neychev; Electron Kebebew
Journal:  Int J Surg Oncol       Date:  2017-05-16

10.  Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias.

Authors:  Max B Albers; Martin Almquist; Anders Bergenfelz; Erik Nordenström
Journal:  Langenbecks Arch Surg       Date:  2020-04-15       Impact factor: 3.445
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.